0091-3057 < 0091-3952 < 0091-4916

Facettes :

List of bibliographic references indexed by 0091-3952

Number of relevant bibliographic references: 94.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
002963 (2005)	Valerie Voon [Canada] ; Elena Moro ; Jean A. Saint-Cyr ; Andres M. Lozano ; Anthony E. Lang	Psychiatric symptoms following surgery for Parkinson's disease with an emphasis on subthalamic stimulation.
002991 (2005)	Sharon Cohen [Canada] ; Morris Freedman	Cognitive and behavioral changes in the Parkinson-plus syndromes.
002994 (2005)	Jean A. Saint-Cyr [Canada]	Basal ganglia: functional perspectives and behavioral domains.
002B52 (2004)	Yoshiaki Furukawa [Canada]	Update on dopa-responsive dystonia: locus heterogeneity and biochemical features.
002D54 (2003)	Joseph King Ching Tsui [Canada]	Treatment of dystonia in Parkinson's disease.
002D67 (2003)	Donald B. Calne [Canada]	Parkinson's disease over the last 100 years.
002D86 (2003)	A Jon Stoessl [Canada] ; Raúl De La Fuente-Fernández	Dopamine receptors in Parkinson's disease: imaging studies.
002E92 (2003)	Susan M. Calne [Canada] ; Edwin Mak [Canada] ; Jeanne Hall [Canada] ; Marie-Jose Fortin [Canada] ; Pamela King [Canada] ; Germaine Mcinnes [Canada] ; Linda Grantier [Canada] ; Sherree Trecartin [Canada] ; Michael Schulzer [Canada]	Validating a quality-of-life scale in caregivers of patients with Parkinson's disease: Parkinson's impact scale (PIMS)
002E95 (2003)	Joseph King Ching Tsui [Canada]	Treatment of dystonia in Parkinson's disease
002F00 (2003)	Andres M. Lozano [Canada]	Surgery for Parkinson's disease, the five W's: Why, who, what, where, and when
002F05 (2003)	Pierre J. Blanchet [États-Unis, Canada] ; Leo Verhagen Metman [États-Unis] ; Thomas N. Chase [États-Unis]	Renaissance of amantadine in the treatment of Parkinson's disease
002F18 (2003)	A. Hadj Tahar [Canada] ; R. Grondin [Canada] ; L. Gregoire [Canada] ; F. Calon [Canada] ; T. Di Paolo [Canada] ; P. J. Bedard [Canada]	New insights in Parkinson's disease therapy: Can levodopa-induced dyskinesia ever be manageable
002F22 (2003)	Ajit Kumar [Canada] ; ZHIGAO HUANG [Canada] ; Raul De La Fuente-Fernandez [Canada]	Mechanisms of motor complications in treatment of Parkinson's disease
002F33 (2003)	Yoshiaki Furukawa [Canada]	Genetics and biochemistry of dopa-responsive dystonia: Significance of striatal tyrosine hydroxylase protein loss
002F37 (2003)	Alex Rajput [Canada] ; Michele Rajput [Canada]	Essential tremor and Parkinsonism
002F40 (2003)	A. Jon Stoessl [Canada] ; Raul De La Fuente-Fernandez [Canada]	Dopamine receptors in Parkinson's disease: Imaging studies
002F50 (2003)	Stephen J. Kish [Canada]	Biochemistry of Parkinson's disease: Is a brain serotonergic deficiency a characteristic of idiopathic Parkinson's disease?
003068 (2002)	Mohamed Shafiq [Canada] ; Anthony E. Lang [Canada]	Myoclonus in parkinsonian disorders
003273 (2001)		Parkinson's disease
003274 (2001)	J. Thomas Hutton [États-Unis] ; Jerry L. Morris [États-Unis]	Vision in Parkinson's disease
003277 (2001)	Ali H. Rajput [Canada]	The protective role of levodopa in the human substantia nigra

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/ISSN.i -k "0091-3952" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/ISSN.i  \
                -Sk "0091-3952" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    ISSN.i
   |clé=    0091-3952
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022